Close Menu

NEW YORK (GenomeWeb) – Precision Therapeutics announced today that it has signed a definitive agreement to merge with Helomics.

Under the terms of the deal, Precision — formerly Skyline Medical — will acquire the 75 percent of Helmomics' shares it does not currently own, having already taken a 25 percent equity stake in the firm in December.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are sampling the wild relatives of modern crops to try to preserve genetic diversity, NPR reports.

Undark reports on a bill introduced this year to the US House of Representatives to strengthen scientific integrity.

MIT's Search for Extraterrestrial Genomes is developing sequencing tools to use to try to detect whether there is any life on Mars, Quartz reports.

In Genome Research this week: post-zygotic mutations in diabetes development, single-cell RNA sequencing study of aging, and more.

Dec
10
Sponsored by
Congenica II

This webinar will discuss the use of next-generation sequencing and an optimized variant interpretation workflow to increase diagnostic yield in complex clinical cases.

Dec
11
Sponsored by
Roche

This webinar will address how two molecular laboratories are implementing tertiary analysis software to improve their precision oncology workflows.